Work with thought leaders and academic experts from Albert Einstein College of Medicine

Dr. John Bilello has over 25 years of experience in the pharmaceutical industry, the biotechnology sector, and academic and government laboratories. He was an Associate Professor at the University of Maryland School of Medicine and Albany Medical College. Dr. Bilello joined GlaxoSmithKline (GSK), where he was the Director of Technology Development in Translational Medicine and Genetics. John assessed external technologies in his technology development role, identifying new investment opportunities for GSK’s Technology Investment Board. His work with GSK’s Human Biomarker Laboratories led to tools for stratifying patients and monitoring efficacy in clinical studies. Specifically, he developed biomarkers for enabling studies of new therapeutics for COPD, diabetes/metabolic syndrome, migraine, and neurodegenerative diseases. Before joining GSK, he was a biochemist at Roche Pharmaceuticals, a Volkswagen Fellow at the University of Hamburg (Germany), and the Director of Preclinical Research and Development at two successful biotechnology companies (SRA Lifesciences and Virco Laboratories). As an enthusiastic entrepreneur, John was a founder and Chief Scientific Officer of Ridge Diagnostics, which developed and commercialized a diagnostic for major depressive disorder. At Ridge, he was an inventor on multiple US and international patents and processes. John has authored over seventy publications in refereed journals and more than ten book chapters. An internationally recognized scientist, he was a member of the editorial board for *Antimicrobial Agents and Chemotherapy* (1995-2009). In addition to an established track record of innovative basic and clinical research, Dr. Bilello has extensive experience in project and organizational management. John was a co-founder and Managing Partner of Innovalyst LLC,  a small business accelerator focused on catalyzing product innovation in the Life Sciences.